Francesco Pallone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesco Pallone has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Luzza
Department of Health Sciences, University of Catanzaro “Magna Graecia”, 88100 Catanzaro, Italy
2 shared publications Giovanni Monteleone
Dipartimento di Medicina Sperimentale, Universita' di Catanzaro, Catanzaro, Italy
2 shared publicationsTiziana Parrello
Dipartimento di Medicina Sperimentale, Universita’ di Catanzaro , Catanzaro
2 shared publicationsAlfredo Fusco
Dipartimento di Medicina Sperimentale, Universita’ di Catanzaro , Catanzaro
1 shared publicationAnnamaria Vecchia
Servizio di Anatomia Patologica, Ospedale Pugliese, Catanzaro, Italy
1 shared publicationAntonella Stella
Dipartimento di Medicina Sperimentale, Universita’ di Catanzaro , Catanzaro
1 shared publication
Latest Publications
- 1 September 1999
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 117 (3) , 469-475
Interferon-gamma (IFN-γ) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC)
IL-12 modulates Th1 immune response during chronic colitis. Mechanisms regulating IL-12 synthesis in human intestine are poorly understood. The aim of this study was to investigate the effect of IFN-γ and PGE2 on lipopolysaccharide (LPS)-stimulated LPMC IL-12 production. Normal LPMC cultures were run in the presence or absence of IFN-γ and/or PGE2 before LPS stimulation. To examine the role of endogenous PGE2 on LPS-stimulated IL-12 release, LPMC cultures were added of indomethacin before LPS stimulation. IL-12, IL-10 and IL-8 were measured by ELISA. No IL-12 was detected in either unstimulated or LPS-stimulated LPMC cultures. In contrast, LPMC released IL-8 (650 ± 125 pg/ml) and IL-10 (75 ± 25 pg/ml) in response to LPS. Treatment of LPMC with IFN-γ facilitated LPS-stimulated IL-12, whereas it completely abrogated IL-10 production. IL-12 release by LPMC stimulated with IFN-γ and LPS was significantly inhibited by exogenous IL-10. The addition of PGE2 to IFN-γ-treated LPMC cultures inhibited in a dose-dependent manner LPS-induced IL-12 secretion. Furthermore, IL-12 was detectable (85 ± 25 pg/ml) in the supernatants of LPMC cultures treated with indomethacin and LPS. In contrast to the effect on IL-12, PGE2 significantly augmented LPS-stimulated LPMC IL-10 production. However, the inhibition of IL-12 by PGE2 was only partially reversed by anti-IL-10. In a simplified model of LPS tolerance, we finally showed that monocyte-derived macrophages exhibited reduced IL-12 production after repeat LPS stimulation. In these cell cultures, indomethacin abrogated the induction of LPS desensitization. IFN-γ and PGE2 modulate differently the LPMC responsiveness to LPS in terms of IL-12 synthesis.
- 1 September 1999
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 117 (3) , 469-475
Interferon-gamma (IFN-γ) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC)
IL-12 modulates Th1 immune response during chronic colitis. Mechanisms regulating IL-12 synthesis in human intestine are poorly understood. The aim of this study was to investigate the effect of IFN-γ and PGE2 on lipopolysaccharide (LPS)-stimulated LPMC IL-12 production. Normal LPMC cultures were run in the presence or absence of IFN-γ and/or PGE2 before LPS stimulation. To examine the role of endogenous PGE2 on LPS-stimulated IL-12 release, LPMC cultures were added of indomethacin before LPS stimulation. IL-12, IL-10 and IL-8 were measured by ELISA. No IL-12 was detected in either unstimulated or LPS-stimulated LPMC cultures. In contrast, LPMC released IL-8 (650 ± 125 pg/ml) and IL-10 (75 ± 25 pg/ml) in response to LPS. Treatment of LPMC with IFN-γ facilitated LPS-stimulated IL-12, whereas it completely abrogated IL-10 production. IL-12 release by LPMC stimulated with IFN-γ and LPS was significantly inhibited by exogenous IL-10. The addition of PGE2 to IFN-γ-treated LPMC cultures inhibited in a dose-dependent manner LPS-induced IL-12 secretion. Furthermore, IL-12 was detectable (85 ± 25 pg/ml) in the supernatants of LPMC cultures treated with indomethacin and LPS. In contrast to the effect on IL-12, PGE2 significantly augmented LPS-stimulated LPMC IL-10 production. However, the inhibition of IL-12 by PGE2 was only partially reversed by anti-IL-10. In a simplified model of LPS tolerance, we finally showed that monocyte-derived macrophages exhibited reduced IL-12 production after repeat LPS stimulation. In these cell cultures, indomethacin abrogated the induction of LPS desensitization. IFN-γ and PGE2 modulate differently the LPMC responsiveness to LPS in terms of IL-12 synthesis.
- Open Access
- 1 July 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (1) , 143-147
Bioactive IL-18 Expression Is Up-Regulated in Crohn’s Disease
An imbalance of immunoregulatory factors is believed to contribute to uncontrolled mucosal Th1 cell activation in Crohn’s disease (CD). IL-18, a macrophage-like cell-derived cytokine, is involved in Th1 clone development, and IFN-γ production. Therefore, IL-18 expression was investigated in CD. Whole mucosal intestinal tissue and lamina propria mononuclear cells (LPMC) of 12 CD and 9 ulcerative colitis (UC) patients and 15 non-inflammatory bowel disease (IBD) controls were tested for IL-18 by semiquantitative RT-PCR and Western blot analysis. Transcripts for IL-18 were found in all samples tested. However, increased IL-18 mRNA accumulation was detected in both mucosal and LPMC samples from CD in comparison to UC and controls. In CD, transcripts for IL-18 were more abundant in the mucosal samples taken from involved areas. An 18-kDa band consistent with mature IL-18 was predominantly found in CD mucosal samples. In mucosal samples from non-IBD controls, IL-18 was present as a 24-kDa polypeptide. Consistently, active IL-1β-converting enzyme (ICE) subunit (p20) was expressed in samples from either CD or UC, whereas, in colonic mucosa from non-IBD controls, ICE was synthesized as precursor (p45) only. To confirm that IL-18 produced in CD tissue was functionally active, CD LPMC were treated with a specific IL-18 antisense oligonucleotide. In these cultures, IL-18 down-regulation was accompanied by a decrease in IFN-γ expression. In aggregate, our data indicate that IL-18 up-regulation is a feature of CD and suggest that IL-18 may contribute to the local immunoinflammatory response in CD.
- 1 July 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (1) , 143-147
Open AccessBioactive IL-18 Expression Is Up-Regulated in Crohn’s Disease
An imbalance of immunoregulatory factors is believed to contribute to uncontrolled mucosal Th1 cell activation in Crohn’s disease (CD). IL-18, a macrophage-like cell-derived cytokine, is involved in Th1 clone development, and IFN-γ production. Therefore, IL-18 expression was investigated in CD. Whole mucosal intestinal tissue and lamina propria mononuclear cells (LPMC) of 12 CD and 9 ulcerative colitis (UC) patients and 15 non-inflammatory bowel disease (IBD) controls were tested for IL-18 by semiquantitative RT-PCR and Western blot analysis. Transcripts for IL-18 were found in all samples tested. However, increased IL-18 mRNA accumulation was detected in both mucosal and LPMC samples from CD in comparison to UC and controls. In CD, transcripts for IL-18 were more abundant in the mucosal samples taken from involved areas. An 18-kDa band consistent with mature IL-18 was predominantly found in CD mucosal samples. In mucosal samples from non-IBD controls, IL-18 was present as a 24-kDa polypeptide. Consistently, active IL-1β-converting enzyme (ICE) subunit (p20) was expressed in samples from either CD or UC, whereas, in colonic mucosa from non-IBD controls, ICE was synthesized as precursor (p45) only. To confirm that IL-18 produced in CD tissue was functionally active, CD LPMC were treated with a specific IL-18 antisense oligonucleotide. In these cultures, IL-18 down-regulation was accompanied by a decrease in IFN-γ expression. In aggregate, our data indicate that IL-18 up-regulation is a feature of CD and suggest that IL-18 may contribute to the local immunoinflammatory response in CD.
- Open Access
- 1 June 1999
- Published by Wiley in FEMS Immunology & Medical Microbiology
- Vol. 24 (2) , 233-238
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis
- 1 June 1999
- Published by Wiley in FEMS Immunology & Medical Microbiology
- Vol. 24 (2) , 233-238
Open AccessChanges in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis